Terms ending in 2027
Every in-force patent on Acclarent, Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,874,838 | Systems and Methods for Transnasal Dilation of Passageways in the Ear, Nose or Throat In force · High confidence | Acclarent, Inc. | In force | High confidence | |
| US 8,702,722 | System and Method for the Simultaneous Automated Bilateral Delivery of Pressure Equalization Tubes In force · High confidence | Tusker Medical, Inc. | In force | High confidence | |
| US 9,216,112 | System and Method for the Simultaneous Bilateral Placement of Pressure Equalization Tubes In force · High confidence | Tusker Medical, Inc. | In force | High confidence | |
| US 10,258,776 | System and Method for Treatment of Target Tissues Within the Ears In force · High confidence | Tusker Medical, Inc. | In force | High confidence | |
| US 8,317,816 | Balloon Catheters and Methods for Treating Paranasal Sinuses In force · Medium confidence | Acclarent, Inc. | In force | Medium confidence | |
| US 9,392,229 | Iontophoresis Methods In force · High confidence | Tusker Medical, Inc. | In force | High confidence | |
| US 8,052,693 | System and Method for the Simultaneous Automated Bilateral Delivery of Pressure Equalization Tubes In force · High confidence | Tusker Medical, Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Acclarent, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.